We chose to carry out studies initially directed at identification of putative mechanisms linking GLP-1R agonism to attenuation of neurodegeneration using two widely used transgenic mouse models of Alzheimer's disease featuring excessive deposition of amyloid plaques [31]. The gene discussed is GLP1R; the disease is Alzheimer disease.